MIM
PRAH

MetLife Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

MetLife Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-32,377
Closed -$5.35M – 2607
2021
Q2 		$5.35M Sell
32,377
-963
-3% -$161K 0.05% 357
2021
Q1 		$5.11M Sell
33,340
-1,764
-5% -$240K 0.05% 378
2020
Q4 		$4.4M Sell
35,104
-1,516
-4% -$170K 0.04% 415
2020
Q3 		$3.71M Sell
36,620
-1,165
-3% -$119K 0.04% 429
2020
Q2 		$3.68M Buy
37,785
+1,480
+4% +$138K 0.04% 420
2020
Q1 		$3.01M Hold
36,305
– – 0.04% 436
2019
Q4 		$4.04M Sell
36,305
-218
-0.6% -$22.4K 0.04% 460
2019
Q3 		$3.62M Buy
36,523
+1,511
+4% +$150K 0.04% 495
2019
Q2 		$3.47M Sell
35,012
-939
-3% -$89.6K 0.04% 534
2019
Q1 		$3.97M Buy
35,951
+294
+0.8% +$30.7K 0.04% 458
2018
Q4 		$3.28M Buy
35,657
+188
+0.5% +$19K 0.04% 497
2018
Q3 		$3.91M Buy
35,469
+3,654
+11% +$380K 0.04% 503
2018
Q2 		$2.97M Buy
31,815
+9,000
+39% +$775K 0.04% 614
2018
Q1 		$1.89M Hold
22,815
– – 0.02% 793
2017
Q4 		$2.08M Buy
+22,815
New +$1.9M 0.02% 781

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

MetLife Investment Management's PRAH Position: Q3 2021 in Review

MetLife Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 32,377 shares — an estimated $5.35M sold.

MetLife Investment Management first reported a position in PRAH in Q4 2017 and held it in 15 quarters. The position peaked at $5.35M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • MetLife Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • MetLife Investment Management sold 32,377 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $5.35M.
  • MetLife Investment Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 15 quarters.
  • MetLife Investment Management's PRA Health Sciences, Inc. position peaked at $5.35M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.